What Researchers Did
The researchers looked back at the medical records of seven patients who had stubborn brain, spine or mucormycosis (a fungal infection) that had not cleared with surgery and antimicrobial drugs, and who were referred for hyperbaric oxygen treatment (HBOT) between 2010 and 2018.
What They Found
This retrospective case series of seven patients with refractory central nervous system infections reported infection resolution in six patients who received HBOT as an add-on to antimicrobial therapy. Four patients had infections after surgery and three had rhino-orbital-cerebral mucormycosis. Before HBOT, patients had an average of four operations and about five months of antimicrobial therapy. After HBOT, six patients had resolution without more operations. One patient with mucormycosis stopped HBOT after the third session because of intolerance. Three patients stopped antimicrobial therapy and four stayed on preventive treatment. The median follow-up was 20 months.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a retrospective review of only seven patients with no comparison group, so it cannot show that HBOT caused the infections to resolve, and one patient stopped treatment early because of intolerance.